Role of Oxidants in Interstitial Lung Diseases: Pneumoconioses, Constrictive Bronchiolitis, and Chronic Tropical Pulmonary Eosinophilia

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="407657.fig.002a" src="https://static.hindawi.com/articles/mi/volume-2011/407657/figures/407657.fig.002a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>Superoxide anion</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="407657.fig.002b" src="https://static.hindawi.com/articles/mi/volume-2011/407657/figures/407657.fig.002b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>Hydrogen peroxide</td></tr></table></td></tr></table>

<table>Reduction in the spontaneous release of oxidants by lavage cells after prednisone therapy in TPE patients following diethylcarbamazine therapy. (a) Superoxide anion. (b) Hydrogen peroxide.</table>

Mediators of Inflammation

fig2

Figure 2

Figure 2: Role of Oxidants in Interstitial Lung Diseases: Pneumoconioses, Constrictive Bronchiolitis, and Chronic Tropical Pulmonary Eosinophilia 